329 related articles for article (PubMed ID: 32996603)
1. Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes.
Flegel WA; Srivastava K; Sissung TM; Goldspiel BR; Figg WD
Vox Sang; 2021 Feb; 116(2):141-154. PubMed ID: 32996603
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).
Gradhand U; Kim RB
Drug Metab Rev; 2008; 40(2):317-54. PubMed ID: 18464048
[TBL] [Abstract][Full Text] [Related]
3. Variation and evolution of the ABC transporter genes ABCB1, ABCC1, ABCG2, ABCG5 and ABCG8: implication for pharmacogenetics and disease.
Silverton L; Dean M; Moitra K
Drug Metabol Drug Interact; 2011; 26(4):169-79. PubMed ID: 22098604
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
5. PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine.
Hirai T; Fukui Y; Motojima K
Biol Pharm Bull; 2007 Nov; 30(11):2185-90. PubMed ID: 17978498
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacogenetics and potential application in personalized medicine.
Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
[TBL] [Abstract][Full Text] [Related]
7. Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo.
Colombo S; Soranzo N; Rotger M; Sprenger R; Bleiber G; Furrer H; Buclin T; Goldstein D; Décosterd L; Telenti A;
Pharmacogenet Genomics; 2005 Sep; 15(9):599-608. PubMed ID: 16041239
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells.
Gotovdorj T; Lee E; Lim Y; Cha EJ; Kwon D; Hong E; Kim Y; Oh MY
J Korean Med Sci; 2014 Sep; 29(9):1188-98. PubMed ID: 25246735
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
Bruhn O; Cascorbi I
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of irinotecan metabolism and transport: an update.
Smith NF; Figg WD; Sparreboom A
Toxicol In Vitro; 2006 Mar; 20(2):163-75. PubMed ID: 16271446
[TBL] [Abstract][Full Text] [Related]
11. The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule.
Jenkinson SE; Chung GW; van Loon E; Bakar NS; Dalzell AM; Brown CD
Pflugers Arch; 2012 Dec; 464(6):601-11. PubMed ID: 23014881
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
Bosch TM
Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
[TBL] [Abstract][Full Text] [Related]
13. Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.
Maeda K; Sugiyama Y
Drug Metab Pharmacokinet; 2008; 23(4):223-35. PubMed ID: 18762709
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan pathway genotype analysis to predict pharmacokinetics.
Mathijssen RH; Marsh S; Karlsson MO; Xie R; Baker SD; Verweij J; Sparreboom A; McLeod HL
Clin Cancer Res; 2003 Aug; 9(9):3246-53. PubMed ID: 12960109
[TBL] [Abstract][Full Text] [Related]
15. International Transporter Consortium commentary on clinically important transporter polymorphisms.
Giacomini KM; Balimane PV; Cho SK; Eadon M; Edeki T; Hillgren KM; Huang SM; Sugiyama Y; Weitz D; Wen Y; Xia CQ; Yee SW; Zimdahl H; Niemi M;
Clin Pharmacol Ther; 2013 Jul; 94(1):23-6. PubMed ID: 23778707
[TBL] [Abstract][Full Text] [Related]
16. cGMP transport by vesicles from human and mouse erythrocytes.
de Wolf CJ; Yamaguchi H; van der Heijden I; Wielinga PR; Hundscheid SL; Ono N; Scheffer GL; de Haas M; Schuetz JD; Wijnholds J; Borst P
FEBS J; 2007 Jan; 274(2):439-50. PubMed ID: 17229149
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations and gene expression of transporters in drug disposition and response.
Huang Y; Penchala S; Pham AN; Wang J
Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):237-54. PubMed ID: 18363540
[TBL] [Abstract][Full Text] [Related]
18. Detergent-free purification of ABC (ATP-binding-cassette) transporters.
Gulati S; Jamshad M; Knowles TJ; Morrison KA; Downing R; Cant N; Collins R; Koenderink JB; Ford RC; Overduin M; Kerr ID; Dafforn TR; Rothnie AJ
Biochem J; 2014 Jul; 461(2):269-78. PubMed ID: 24758594
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.
Wada M
Cancer Lett; 2006 Mar; 234(1):40-50. PubMed ID: 16377077
[TBL] [Abstract][Full Text] [Related]
20. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
